This page is maintained and edited by John Eon (Editor at World Wide News Flash since January, 2010).
You can contribute to this page by sending an email to [email protected] or by using our contact form below.

Avandia Fda

July 15, 2010 Split Decision From FDA Panel On Avandia | Health News Posted by John Eon STORY HIGHLIGHTSNEW: Glaxo says Avandia remains available to "appropriate" patientsNEW: FDA promises to issue a decision "as soon as. [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 FDA Debates Safety Of Popular Diabetes Drug | Abc7.com Posted by John Eon The FDA began a two-day meeting Tuesday to discuss the side effects and safety of the diabetes pill Avandia. [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 Avandia And FDA On Trial Send by Terisita Avandia obviously causes heart attacks and is on trial with FDA hearings this week, but is the FDA also on Trial? [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 Avandia Should Remain On The Market, Majority Of FDA Advisor Send by jwaf Federal advisers delivered a decidedly mixed verdict Wednesday on the diabetes drug Avandia, with a significant number of experts voting to recommend that it be be removed from the market because of safety concerns but a majority voting to keep it available, perhaps with tough new restrictions an [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 Docs Saying No To Avandia Before FDA Vote Send by lilharut As the US Food and Drug Administration conducts safety hearings on GlaxoSmithKline's diabetes drug Avandia, many doctors are choosing on their own to discontinue writing prescriptions for the drug, [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 FDA Faces High Stakes In Avandia Decision - WSJ.com Posted by John Eon 12 Jul 2010 [...] Against a backdrop of legal maneuvers and internal FDA struggles, a panel of outside medical experts convenes Tuesday to debate whether the [...] Rating: No stars. Rate up / Rate down Report to moderator

July 15, 2010 FDA: Avandia Stays On Market Posted by John Eon The vote is 20-12 against withdrawing GSK?s troubled drug Avandia from the marketplace. Essentially, the FDA says that ? in spite of the earlier vote the committee had on positively acknowledging the cardiac risks associated with the drug ? those risks were not deemed strong enough to warrant remova [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 Avandia Debate Spotlights Key FDA Decision Makers - BLACK ... Posted by John Eon BLACK ENTERPRISE is your ultimate source for wealth creation and financial empowerment. [...] Avandia Debate Spotlights Key FDA Decision Makers. Article written by Associated Press. [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 FDA Struggles For Avandia's Verdict | TopNews New Zealand Send by Ketan Mukherjee There is a lot at stake for the FDA, Avandia manufacturer, GlaxoSmithKline PLC and Avandia's opponent drug Actos, made by Takeda Pharmaceutical Co. The pharmaceutical industry, especially, is worried that the argument will holdup new [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 FDA Divided On Avandia : Video - Ansamblu.COM Send by lacea Advertisement ansamblu.com We Did not Allow you to Use usposttoday.com Rss Feed As committee members debate whether the diabetes drug Avandia should be pulled from the market, Dr. Jon LaPook reports the FDA is deeply divided. [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 Day 1 Of The FDA Avandia Panel: Live Blogging The Afternoon ... Send by Larry Husten Day 1 of the FDA Avandia Panel: Live Blogging the Afternoon. Posted on July 13, 2010 by Larry Husten. 6:21: Kaul winds up to deliver a knock-out punch to the Nissen meta-analysis but Nissen pulls a judo move and turns the question [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 GSK Issues Statement In Response To FDA Avandia Panel CardioBrief Send by Larry Husten GlaxoSmithKline [NYSE: GSK] confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 FDA Votes For Drug Sales On Avandia Not Safety Send by politicol Well it appears 18 people on the Avandia FDA panel that voted for Avandia to continue to kill American Diabetics are in the pockets of drug company influence. No Surprises there. [...] Rating: No stars. Rate up / Rate down Report to moderator

July 15, 2010 FDA Avandia Hearing Update ? Committee Votes Increased Risk Of CV ... Send by Thomas Sullivan After almost two days of rigorous debate, the time for the FDA vote on the fate of Avandia is upon us. The 33 member FDA advisory committee on rosiglitizone has voted that despite causing increase risk in cardiovascular events Avandia. [...] Rating: No stars. Rate up / Rate down Report to moderator

July 15, 2010 Day 1 Of The FDA Avandia Panel- Live Blogging The Morning ... Send by Larry Husten 11:41: Matt Herper: Ellis Unger seems more concerned with defending FDA, not Avandia. 11:39: Can we trust the sponsor of RECORD? Marciniak should not have reanalyzed RECORD. 11:38: Ungar: Marciniak is one tenacious reviewer. But? [...] Rating: 3 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 Avandia Health Risks | FDA Panel Votes: Bad News For Avandia Send by US Drug Recall While the FDA does not have to follow the advice of the expert panel, it most often does so. The final decision about the future of a potential Avandia Recall will be made by the current FDA Commissioner at a later date. [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 Avandia Survives FDA Panel, But Just Barely The Science Business ... Posted by John Eon A FDA panel has voted to keep drug Avandia on the market, but wants severe restrictions on the drug. Overall, 12 of 33 panel members voted for immediate recall, while 20 others [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 15, 2010 FDA Panel Says Avandia Should Stay On Market Despite Evidence Of ... Posted by John Eon A majority of federal health experts voted Wednesday to keep the controversial diabetes pill Avandia on the market despite evidence that it increases the risk of heart attack. [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

---

Submit article

Name:
E-Mail:
Source:
Article:
Please complete all the fields in order to take your article in consideration.